News Focus
News Focus
Replies to #29669 on Biotech Values
icon url

walldiver

06/05/06 6:57 PM

#29678 RE: kokostrollet #29669

re CA4P...

Too small of an indication is no excuse anymore. Companies can make a bundle in orphan drug indications, just look at GENZ and BMRN. It's also a way of picking off the low-hanging fruit on the way to off-label use in other indications.